7Baggers

LivaNova PLC
(NASDAQ:LIVN) 

LIVN stock logo

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygena...

Founded: 1987
Full Time Employees: 4,000
Sector: Healthcare
Industry: Medical Devices
Pharmaceuticals
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-10-18 2015-09-30 
                                               
      net revenue
    		362,258,000 360,921,000 357,753,000 352,524,000 316,855,000 321,830,000 318,120,000 318,575,000 294,912,000 310,132,000 286,113,000 293,882,000 263,418,000 274,874,000 252,605,000                             
      cost of sales
    		118,509,000 121,148,000 112,898,000 113,536,000 96,080,000 102,476,000 92,856,000 99,710,000 87,522,000 119,965,000 84,310,000 88,685,000 89,335,000 91,357,000 81,687,000 69,801,000 71,732,000 72,543,000 83,105,000 90,803,000          67,722,750 94,300,000 91,993,000 84,598,000 34,819,000 108,233,000 108,888,000 101,463,000 111,311,000 106,454,000 9,433,000 7,595,000 6,765,872  
      gross profit
    		243,749,000 239,773,000 244,855,000 238,988,000 220,775,000 219,354,000 225,264,000 218,865,000 207,390,000 190,167,000 201,803,000 205,197,000 174,083,000 183,517,000 170,918,000 184,350,000 168,443,000 197,521,000 170,110,000 173,680,000          132,599,000 174,348,000 193,963,000 162,085,000 56,621,000 199,789,000 210,776,000 184,434,000 161,796,000 188,814,000 71,578,000 66,477,000 66,651,322  
      yoy
    		10.41% 9.31% 8.70% 9.19% 6.45% 15.35% 11.63% 6.66% 19.13% 3.62% 18.07% 11.31% 3.35% -7.09% 0.47% 6.14%              134.19% -12.73% -7.98% -12.12% -65.00% 5.81% 194.47% 177.44% 142.75%      
      qoq
    		1.66% -2.08% 2.45% 8.25% 0.65% -2.62% 2.92% 5.53% 9.06% -5.77% -1.65% 17.87% -5.14% 7.37% -7.29% 9.44% -14.72% 16.11% -2.06%           -23.95% -10.11% 19.67% 186.26% -71.66% -5.21% 14.28% 13.99% -14.31% 163.79% 7.67% -0.26%   
      gross margin %
    		Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% 72.54% 70.13% 73.14% 67.18% 65.67% 0% 0% 0% 0% 0% 0% 0% 0% 0% 44.65% 64.08% 67.47% 64.73% 58.91% 64.52% 65.58% 64.69% 52.08% 63.95% 88.36% 89.75% 90.78% NaN% 
      operating expenses:
    		                                           
      selling, general, and administrative
    		143,568,000 143,365,000 138,522,000 137,780,000 133,667,000 135,623,000 131,661,000 129,118,000                                    
      research and development
    		58,695,000 52,123,000 48,577,000 47,185,000 37,879,000 43,308,000 48,805,000 44,737,000 45,664,000 46,166,000 46,541,000 51,124,000 49,986,000 44,933,000 35,725,000 34,229,000 40,918,000 34,828,750 42,133,000 52,557,000 44,625,000 44,480,000 47,368,000 25,152,000 35,902,000 25,866,000 45,904,000 34,544,000 43,575,000 37,640,000 42,417,000 34,215,000 31,752,000 5,611,000 31,393,000 43,007,000 29,651,000 28,378,000 32,175,000 9,804,000 10,689,000 10,816,868  
      other operating expense
    		15,000 1,707,000 3,744,000       7,286,250 16,010,000 10,825,000 2,310,000                               
      operating income
    		41,471,000 42,578,000 54,012,000 54,183,000 48,617,000 37,021,000 35,618,000 40,166,000 16,246,000 -87,990,000 4,458,000 17,376,000 -2,342,000 -22,678,000 -131,973,000 31,756,000 9,505,000                           
      yoy
    		-14.70% 15.01% 51.64% 34.90% 199.26% -142.07% 698.97% 131.16% -793.68% 288.00% -103.38% -45.28% -124.64%                               
      qoq
    		-2.60% -21.17% -0.32% 11.45% 31.32% 3.94% -11.32% 147.24% -118.46% -2073.76% -74.34% -841.93% -89.67% -82.82% -515.58% 234.10%                            
      operating margin %
    		Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% -Infinity% Infinity% Infinity% -Infinity% -Infinity% -Infinity% 12.49% 3.96% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% NaN% 
      snia environmental liability expense
    		 -1,738,000 -1,745,000 -1,677,000 -360,393,000                                       
      interest expense
    		-8,291,000 -10,857,000 -10,863,000 -12,280,000 -15,286,000 -15,767,000 -15,878,000 -15,532,000 -15,893,000 -15,621,000 -14,986,000 -14,809,000 -13,437,000 -13,361,000 -12,661,000 -14,388,000 -7,840,000 -6,345,000 -11,355,000 -16,515,000 -15,936,000 -15,600,000 -14,673,000 -5,715,000 -4,849,000 -4,601,000 -4,774,000 -4,054,000 -1,662,000 -2,075,000 -2,633,000 -3,006,000 -2,111,000 -2,483,000 -1,421,000 -1,578,000 -2,315,000 -17,281,000 3,495,000 22,000 7,000   
      foreign exchange and other income
    		-5,695,000 -2,349,000 -7,493,000 -4,255,000 11,416,000 35,226,000 24,701,000 -3,045,000 -9,071,000 9,315,000 8,550,000 2,713,000 25,547,000 5,795,000 38,528,000                             
      income before income tax
    		27,485,000 27,634,000 33,911,000 33,320,000                                        
      income tax expense
    		4,340,000 -3,282,000 7,114,000 6,151,000 11,656,000 589,000 11,525,000 5,227,000 7,717,000 -110,652,000 5,308,000 4,097,000 2,371,000 4,704,000 1,295,000 2,515,000 2,537,000 2,104,000 2,098,000 4,140,000 2,856,000 4,395,250 -3,990,000 66,285,000  -6,722,000 -10,653,000 -6,164,000 -6,614,000 -69,832,000 -2,660,000 -1,030,000 3,893,000 39,073,000 1,913,000 3,313,000 5,655,000 -9,763,000 9,731,000 6,799,000 6,350,000   
      loss from equity method investments
    		-851,000   -8,000 -20,000   -29,000 -26,000                                   
      net income
    		22,294,000 30,906,000 26,784,000 27,161,000 -327,322,000 55,891,000 32,953,000 16,333,000 -41,943,000 16,339,000 -7,318,000 1,155,000 7,370,000 1,661,000 -107,344,000 16,444,000 2,993,000 -8,565,000 -42,237,000 -55,318,000 -29,698,000 -279,826,000 -14,772,000 -87,993,000 37,583,000 -143,230,000 32,118,000 -29,215,000 -14,849,000 -210,561,000 -7,177,000 15,066,000 13,273,000 -111,688,000 27,830,000 47,498,000 11,271,000 -29,799,000 -1,569,000 12,419,000 10,514,000 17,273,190 1,000 
      yoy
    		-106.81% -44.70% -18.72% 66.30% 680.40% 242.07% -550.30% 1314.11% -669.10% 883.68% -93.18% -92.98% 146.24% -119.39% 154.15% -129.73% -110.08% -96.94% 185.93% -37.13% -179.02% 95.37% -145.99% 201.19% -353.10% -31.98% -547.51% -293.91% -211.87% 88.53% -125.79% -68.28% 17.76% 274.80% -1873.74% 282.46% 7.20% -272.52% -157000.00%     
      qoq
    		-27.87% 15.39% -1.39% -108.30% -685.64% 69.61% 101.76% -138.94% -356.70% -323.27% -733.59% -84.33% 343.71% -101.55% -752.79% 449.42% -134.94% -79.72% -23.65% 86.27% -89.39% 1794.30% -83.21% -334.13% -126.24% -545.95% -209.94% 96.75% -92.95% 2833.83% -147.64% 13.51% -111.88% -501.32% -41.41% 321.42% -137.82% 1799.24% -112.63% 18.12% -39.13% 1727219.00%  
      net income margin %
    		Infinity% Infinity% Infinity% Infinity% -Infinity% Infinity% Infinity% Infinity% -Infinity% Infinity% -Infinity% Infinity% Infinity% Infinity% -Infinity% 6.47% 1.25% -3.17% -16.68% -20.92% -11.99% -103.81% -6.15% -48.29% 15.50% -49.80% 11.96% -10.54% -5.92% -70.90% -2.64% 5.24% 5.30% -116.20% 8.99% 14.78% 3.95% -9.59% -0.53% 15.33% 14.19% 23.53% NaN% 
      basic earnings per share
    		0.41                                           
      diluted earnings per share
    		0.4                                           
      basic weighted-average shares outstanding
    		54,688                                           
      diluted weighted-average shares outstanding
    		55,944                                           
      loss on debt extinguishment
    		   -2,651,000     -25,482,000          -60,238,000                         
      income from equity method investments
    		 -10,250 -13,000   -4,500 37,000   -21,750 -32,000   -6,000 57,000                             
      basic income per share
    		 0.56 0.49 0.5  1.03 0.61 0.3 -0.78 0.31 -0.14 0.02 0.14   0.31 0.06                 0.45 0.58 0.99 0.23   0.48 0.4 0.65 0.02 
      diluted income per share
    		 0.56 0.49 0.5  1.03 0.6 0.3 -0.78 0.3 -0.14 0.02 0.14   0.3 0.06                 0.448 0.57 0.98 0.23   0.47 0.4 0.64 0.02 
      shares used in computing basic income per share
    		 19 54,630 54,577  46 54,352 54,238 54,008 102 53,989 53,803 53,617   53,506 53,300    48,736 10 48,652 48,611 48,485 20 48,395 48,342 48,246 13 48,637 48,487 48,324 27 48,181 48,140 48,067   25,996 26,024 26,574,687 50,001 
      shares used in computing diluted income per share
    		 19 55,153 54,708  48 54,585 54,591 54,008 105 53,989 53,977 53,900   54,080 54,176    48,736 10 48,652 48,611 48,769 20 48,820 48,342 48,246 -930 48,637 49,338 49,187 162 48,534 48,303 48,178   26,228 26,269 26,791,871 50,001 
      other operating expenses
    		   -160,000 612,000 3,402,000 9,180,000 4,844,000 15,617,000     5,018,000 23,140,000 1,883,000 -505,000 8,357,000 1,067,000 33,236,000                        
      loss before income tax
    		    -315,646,000                                       
      basic loss per share
    		    -6.01         -0.41 -2.01                       -0.168 -0.03     
      diluted loss per share
    		    -6.01         -0.41 -2.01                       -0.168 -0.03     
      shares used in computing basic loss per share
    		    54,421         13,368.5 53,534   885 51,582 48,928                  12,254 49,075     
      shares used in computing diluted loss per share
    		    54,421         13,368.5 53,534   885 51,582 48,928                  12,254 49,075     
      income before tax
    		     56,480,000 44,441,000 21,589,000 -34,200,000 3,267,500 -1,978,000 5,280,000 9,768,000   19,001,000 5,569,000                           
      selling, general and administrative
    		        129,863,000 133,334,000 134,794,000 125,872,000 124,129,000 87,409,250 114,630,000 116,482,000 118,525,000 86,867,750 109,042,000 122,748,000 112,618,000 110,346,000 99,199,000 98,048,000 120,177,000 130,610,000 123,015,000 127,213,000 125,704,000 122,231,000 115,136,000 123,439,000 104,161,000 26,617,000 121,177,000 120,369,000 112,397,000 125,925,000 107,553,000 33,706,000 29,690,000 29,572,754  
      impairment of goodwill
    		              129,396,000                             
      losses from equity method investments
    		           -28,000 -27,000   -42,000 -39,000 -39,000 -28,000 -41,000 -40,000 -43,000 -48,000 -44,000 -129,000     -17,000  -265,000 -362,000 3,353,000 -1,590,000 -15,397,000 -3,085,000 -41,994,000 13,129,000     
      loss before tax
    		             -20,384,000 -106,106,000                             
      net sales
    		               254,151,000 240,175,000 270,064,000 253,215,000 264,483,000 247,603,000 269,555,000 240,083,000 182,206,000 242,397,000 287,590,000 268,610,000 277,169,000 250,801,000 296,983,000 272,082,000 287,498,000 250,398,000 96,121,000 309,664,000 321,387,000 285,105,000 310,641,000 295,268,000 81,011,000 74,072,000 73,417,194  
      yoy
    		               -3.91% -3.00% 0.19% 5.47% 45.16% 2.15% -6.27% -10.62% -34.26% -3.35% -3.16% -1.28% -3.59% 0.16% 208.97% -12.14% -10.54% -12.17% -69.06% 4.88% 296.72% 284.90% 323.12% NaN%     
      qoq
    		               5.82% -11.07% 6.65% -4.26% 6.82% -8.14% 12.28% 31.76% -24.83% -15.71% 7.07% -3.09% 10.51% -15.55% 9.15% -5.36% 14.82% 160.50% -68.96% -3.65% 12.73% -8.22% 5.21% 264.48% 9.37% 0.89% NaN%  
      foreign exchange and other income/
    		               1,633,000                            
      foreign exchange and other gains
    		                3,904,000 -20,851,000 13,436,000 50,000  126,750 3,420,000  -1,914,000 -1,741,000 327,000  729,000 -811,000 -727,000 -70,000 -273,000 127,000 491,000 -2,973,000 3,439,000       
      operating income from continuing operations
    		                 -5,354,000 17,868,000  -4,423,000 -5,534,250 -7,508,000  608,000 -143,976,000 25,761,000 -29,876,000 -20,779,000 -276,452,000 -5,757,000 21,607,000 12,530,000           
      interest income
    		                 142,000 178,000 189,000 -74,000 -351,000 47,000 287,000 148,000 179,000 151,000 224,000 249,000 -16,000 184,000 232,000 447,000 594,000 199,000 252,000 273,000 2,817,000 -585,000 -47,000 -38,000 43,157  
      loss from continuing operations before tax
    		                 -6,422,000 -40,111,000 -51,137,000 -26,802,000   -21,664,000 -6,007,000                   
      net income from continuing operations
    		                 -8,565,000 -42,237,000 -55,318,000 -29,698,000 -279,328,000 -14,772,000 -87,993,000 38,578,000 -143,417,000 32,118,000 -29,393,000 -14,849,000 -209,539,000 -6,273,000 19,528,000 17,822,000           
      net loss from discontinued operations, net of tax
    		                        -995,000                   
      basic loss per share:
    		                                           
      continuing operations
    		                 -0.12 -0.82 -1.13 -0.61 -5.75 -0.3 -1.81 0.8 -2.97 0.66 -0.61 -0.31 -4.32 -0.13 0.4 0.37           
      discontinued operations
    		                     -0.01   -0.02   0.01  -0.03 -0.02 -0.09 -0.1           
      diluted loss per share:
    		                                           
      operating loss from continuing operations
    		                   -34,861,000    -15,237,000                    
      costs and expenses:
    		                                           
      cost of sales - exclusive of amortization
    		                    79,216,000 95,910,000 86,467,000 56,762,000 68,923,000 78,311,000 86,128,000 74,942,000 84,254,000               
      product remediation
    		                    68,000 992,000 1,133,000 4,269,000 1,466,000 4,641,000 3,076,000 5,113,000 2,947,000 1,989,000 3,434,000 1,542,000 3,715,000 4,681,000 1,642,000 1,723,000 -792,000       
      merger and integration expenses
    		                    630,000 717,000 1,094,000 2,048,000 3,474,000 9,112,000 6,716,000 4,378,000 3,251,000 4,392,000 12,659,000 4,409,000 2,960,000 7,785,000 2,013,000 3,522,000 2,208,000  7,576,000 6,549,000 8,692,000   
      restructuring expenses
    		                    6,092,000 5,546,000 -349,000 794,000 1,580,000 7,691,000 698,000 1,332,000 2,533,000 13,122,000 436,000 476,000 1,881,000 4,996,000 792,000 1,118,000 10,150,000 18,724,000 4,381,000     
      revaluation of disposal group
    		                    -966,000                       
      amortization of intangibles
    		                    6,699,000 8,966,000 9,685,000 9,394,000 10,267,000 10,685,000 11,146,000 9,228,000 9,316,000 9,119,000 9,457,000 9,817,000 8,801,000 -2,301,000 12,350,000 11,681,000 11,414,000 11,552,000 11,775,000 257,000 685,000   
      litigation provision
    		                    3,044,000 -64,000 2,994,000 976,000                    
      foreign exchange and other losses
    		                    -6,369,000   -999,000    -1,851,000                
      basic income per share:
    		                                           
      diluted income per share:
    		                                           
      impairment of intangible assets
    		                         89,000,000  50,295,000                
      income from continuing operations before tax
    		                     -11,596,250 -18,714,000   -150,139,000 21,465,000 -35,557,000 -21,463,000 -279,354,000 -8,933,000 18,763,000 22,077,000           
      net income from discontinued operations, net of tax
    		                     -498,000    187,000  178,000                
      income tax benefit
    		                        -44,714,000                 9,024,543  
      insurance recovery
    		                         -8,458,500 -33,834,000                 
      gain on acquisition
    		                                           
      total operating expenses
    		                             125,504,000 180,105,000 172,356,000 149,555,000 42,708,000 167,725,000 179,697,000 165,820,000 198,249,000 165,829,000 50,316,000 49,756,000 40,389,622  
      gain on acquisitions
    		                                           
      net income from discontinued operations
    		                             -2,478,750 -904,000 -4,462,000            
      gain on acquisition of imthera medical, inc.
    		                                11,484,000           
      net loss from discontinued operations
    		                                -4,549,000           
      income from operations
    		                                 20,439,250 32,064,000 31,079,000 18,614,000 -36,453,000 22,985,000 21,262,000 16,721,000 26,261,700  
      gain on acquisition of caisson interventional, llc
    		                                   39,428,000        
      income before income taxes
    		                                 29,388,000 31,333,000 66,208,000 20,011,000 -36,332,000 21,291,000 19,218,000 16,864,000 26,297,733 1,000 
      litigation related expenses
    		                                     1,169,500 2,369,000     
      impairment of investment
    		                                       2,064,000    
      foreign exchange and other - loss
    		                                     500 -1,216,000 5,000 -112,000   
      operating expenses
    		                                           
      merger related expenses
    		                                           
      other income
    		                                         -7,124 1,000 
      litigation settlement
    		                                           
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-10-18 2015-09-30 
                                                 
        assets
      		                                           
        current assets:
      		                                           
        cash and cash equivalents
      		539,706,000 635,552,000 646,079,000 593,638,000 738,437,000 428,858,000 346,366,000 329,237,000 309,191,000 266,504,000 233,941,000 222,935,000 214,340,000 214,172,000 231,114,000 109,022,000 128,737,000 207,992,000 181,846,000 329,386,000 252,539,000 252,832,000 227,811,000 232,549,000 125,823,000 61,137,000 75,313,000 44,511,000 50,776,000 47,204,000 79,948,000 47,380,000 64,964,000 93,615,000 65,158,000 42,690,000 62,719,000 39,789,000 63,632,000 63,886,000 87,468,000 189,776,521  
        accounts receivable
      		229,273,000 215,985,000 211,579,000 220,195,000 202,082,000 193,158,000 197,162,000 200,889,000 209,431,000 215,072,000 189,871,000 185,881,000 178,318,000 183,110,000 172,093,000 176,949,000 182,112,000 185,354,000 182,008,000 182,180,000 180,707,000 184,356,000 191,892,000 186,144,000 225,347,000 257,769,000 243,179,000 256,121,000 247,059,000 256,135,000 252,304,000 261,915,000 279,828,000 282,145,000 314,041,000 305,355,000 271,534,000 275,730,000 284,345,000 299,633,000 288,537,000 45,567,279  
        inventories
      		165,504,000 164,701,000 167,538,000 165,350,000 154,017,000 147,566,000 162,264,000 154,722,000 153,176,000 147,887,000 161,539,000 156,446,000 142,453,000 129,379,000 122,041,000 119,415,000 114,844,000 105,840,000 123,733,000 127,168,000 124,523,000 126,675,000 178,091,000 177,246,000 170,256,000 164,154,000 167,756,000 168,669,000 161,267,000 153,535,000 153,056,000 157,831,000 154,326,000 144,470,000 214,593,000 204,680,000 192,388,000 183,489,000 197,649,000 192,730,000 210,762,000 25,935,518  
        prepaid and refundable taxes
      		41,272,000 48,606,000 27,531,000 32,785,000 29,338,000 30,544,000 23,858,000 21,931,000 22,543,000 20,145,000 25,505,000 26,302,000 24,342,000 31,708,000 26,456,000 30,917,000 29,168,000 37,621,000 36,029,000 36,182,000 36,632,000 60,240,000 43,316,000 41,662,000 53,094,000 37,779,000 38,093,000 74,275,000 47,225,000 46,852,000 50,264,000 51,944,000 47,061,000 46,274,000 58,969,000 55,584,000        
        prepaid expenses and other current assets
      		38,482,000 36,769,000 44,422,000 54,174,000 47,277,000 32,362,000 43,253,000 36,026,000 39,184,000 27,182,000 44,230,000 38,846,000 34,946,000 24,988,000 23,593,000 35,357,000 41,033,000 35,745,000 26,811,000 28,815,000 28,754,000 24,792,000 32,026,000 34,838,000 42,402,000 28,604,000 22,505,000 24,868,000 34,275,000 29,571,000 37,666,000 35,621,000 31,100,000 39,037,000 55,176,000 49,213,000 56,047,000 60,450,000 51,850,000 51,797,000 38,560,000   
        total current assets
      		1,014,237,000 1,101,613,000 1,097,149,000 1,066,142,000 1,171,151,000 1,127,186,000 1,093,113,000 1,046,689,000 1,040,017,000 988,158,000 953,867,000 941,835,000 903,017,000 886,136,000 851,222,000 771,927,000 809,623,000 679,181,000 646,355,000 809,102,000 690,630,000 719,434,000 673,136,000 672,439,000 616,922,000 549,443,000 546,846,000 568,444,000 540,602,000 533,297,000 573,238,000 554,691,000 848,071,000 869,858,000 722,054,000 671,381,000 660,677,000 620,073,000 647,330,000 662,338,000 683,669,000 282,405,984 76,000 
        property, plant, and equipment
      		255,483,000 242,603,000 218,510,000 195,418,000 177,681,000 170,260,000 169,317,000 158,055,000                                    
        goodwill
      		785,590,000 792,840,000 791,034,000 793,365,000 761,911,000 750,006,000 781,553,000 766,368,000 771,817,000 782,941,000 767,055,000 779,212,000 774,447,000 768,787,000 742,370,000 898,070,000 896,599,000 899,525,000 905,154,000 918,275,000 909,992,000 922,318,000 918,478,000 902,204,000 888,573,000 915,794,000 945,544,000 961,715,000 952,117,000 956,815,000 969,277,000 965,697,000 875,564,000 784,242,000 781,070,000 763,525,000 698,276,000 691,712,000 731,144,000 731,174,000 764,540,000   
        intangible assets
      		224,556,000 229,964,000 234,530,000 239,143,000 236,594,000 237,294,000 248,545,000 248,195,000 253,927,000 261,178,000 347,672,000 357,420,000 364,056,000 368,559,000 365,026,000 389,379,000 390,455,000 399,682,000 408,954,000 419,182,000 423,850,000 437,636,000 583,818,000 583,490,000 586,988,000 607,546,000 699,493,000 721,033,000 758,528,000 770,439,000 784,264,000 798,434,000 691,994,000 535,397,000 717,646,000 713,176,000 605,780,000 609,197,000 650,366,000 659,285,000 674,737,000 10,401,923  
        operating lease assets
      		54,532,000 55,519,000 51,197,000 50,677,000 48,160,000 46,837,000 51,599,000 49,737,000 50,260,000 50,845,000 31,533,000 34,169,000 36,339,000 35,830,000 34,976,000 38,419,000 38,167,000 40,600,000 46,215,000 49,891,000 49,861,000 50,525,000 52,834,000 51,114,000 52,677,000 54,372,000 54,283,000 56,831,000 57,070,000               
        investments
      		18,492,000 20,291,000 15,049,000 16,163,000 22,721,000 25,084,000 18,097,000 17,217,000 22,675,000 22,843,000 22,698,000 21,726,000 21,471,000 16,266,000 13,941,000 13,965,000 16,745,000 16,598,000 16,580,000 15,275,000 36,772,000 31,094,000 30,358,000 30,245,000 30,040,000 27,256,000 24,942,000 25,095,000 24,762,000 24,823,000 24,113,000 21,130,000 22,084,000 34,492,000 46,380,000 41,013,000 58,728,000 61,092,000 67,435,000 72,216,000 77,682,000   
        deferred tax assets
      		109,816,000 110,983,000 107,305,000 109,810,000 109,455,000 111,855,000 109,992,000 113,011,000 113,687,000 118,858,000 1,506,000 2,113,000 1,533,000 1,384,000 1,415,000 2,422,000 2,699,000 2,197,000 2,012,000 1,883,000 2,921,000 2,990,000 22,673,000 23,148,000 89,013,000 68,676,000 53,577,000 97,622,000 74,876,000 68,146,000 65,808,000 65,539,000 68,901,000 11,559,000 4,356,000 11,981,000 9,401,000  6,010,000 8,300,000 157,811,000   
        long-term derivative assets
      		38,277,000 36,551,000 28,011,000 21,658,000 17,190,000 23,735,000 35,368,000 39,553,000 41,617,000 38,496,000 43,669,000 42,034,000 31,014,000 54,393,000 48,223,000 61,608,000 96,717,000    84,852,000 72,302,000                      
        other assets
      		15,368,000 15,689,000 14,798,000 14,326,000 13,883,000 14,132,000 14,374,000 14,363,000 13,365,000 12,063,000 12,115,000 13,478,000 13,951,000 16,231,000 16,543,000 17,143,000 17,921,000 13,102,000 25,411,000 25,499,000 12,399,000 11,247,000 49,942,000 54,353,000 6,689,000 7,356,000 5,749,000 5,821,000 5,642,000 4,781,000 5,520,000 5,489,000 6,561,000 75,984,000 117,855,000 121,445,000 132,664,000 130,698,000 149,555,000 146,546,000 5,521,000 2,079,790  
        total assets
      		2,516,351,000 2,606,053,000 2,557,583,000 2,506,702,000 2,558,746,000 2,506,389,000 2,521,958,000 2,453,188,000 2,459,602,000 2,429,563,000 2,329,417,000 2,341,555,000 2,294,888,000 2,294,773,000 2,212,878,000 2,336,245,000 2,416,883,000 2,200,951,000 2,203,409,000 2,396,522,000 2,369,169,000 2,411,351,000 2,521,748,000 2,502,663,000 2,454,436,000 2,411,797,000 2,509,941,000 2,621,659,000 2,599,544,000 2,549,701,000 2,610,680,000 2,597,136,000 2,704,876,000 2,503,891,000 2,603,130,000 2,533,685,000 2,370,647,000 2,342,631,000 2,496,960,000 2,524,865,000 2,617,710,000 357,647,076 76,000 
        liabilities and shareholders’ equity
      		                                           
        current liabilities:
      		                                           
        current debt obligations
      		2,628,000 31,472,000 85,440,000 82,133,000 79,570,000 78,004,000 21,951,000 19,742,000 19,704,000 18,111,000 19,027,000 19,074,000 22,297,000 23,434,000 21,695,000 6,240,000 4,752,000 229,673,000 227,773,000 232,012,000 11,788,000 13,343,000 13,953,000 7,449,000 223,314,000 77,396,000 68,777,000 37,725,000 39,442,000 28,794,000 48,983,000 110,588,000 119,708,000 84,034,000 52,074,000 55,776,000 45,456,000 47,650,000 53,617,000 68,871,000 75,539,000   
        accounts payable
      		99,148,000 97,157,000 88,156,000 86,934,000 87,640,000 69,726,000 77,893,000 81,323,000 75,944,000 80,845,000 62,780,000 78,212,000 75,730,000 74,310,000 69,616,000 74,346,000 73,921,000 68,000,000 60,248,000 61,328,000 62,448,000 73,668,000 71,596,000 69,065,000 91,224,000 85,892,000 75,522,000 88,516,000 80,199,000 76,735,000 88,883,000 86,914,000 89,922,000 85,915,000 102,651,000 105,109,000 101,954,000 92,952,000 104,549,000 121,151,000 118,855,000 15,605,005  
        accrued liabilities and other
      		102,649,000 94,573,000 92,229,000 103,240,000 108,437,000 118,485,000 104,523,000 97,971,000 94,029,000 107,301,000 89,680,000 82,038,000 96,353,000 75,595,000 79,008,000 83,952,000 92,026,000 88,937,000 97,504,000 100,227,000 92,034,000 95,408,000 98,308,000 97,238,000 93,539,000 120,100,000 128,456,000 140,728,000 150,536,000 124,285,000 118,733,000 86,153,000 81,748,000 78,942,000 92,212,000 90,046,000        
        snia environmental liability
      		389,485,000 396,242,000 394,587,000 392,268,000 360,393,000                                       
        current contingent consideration
      		59,589,000 50,030,000 49,041,000 48,265,000                                        
        current litigation provision liability
      		9,643,000 12,552,000 16,499,000 12,171,000 13,210,000 12,918,000 16,098,000 15,968,000 16,980,000 10,756,000 26,704,000 22,352,000 19,311,000 29,481,000 43,989,000 30,960,000 30,126,000 32,845,000 33,526,000 53,177,000 26,570,000 28,612,000 34,790,000 37,420,000 43,025,000 146,026,000 121,468,000 256,581,000 252,051,000 161,851,000              
        taxes payable
      		41,704,000 33,133,000 21,373,000 34,495,000 39,549,000 32,456,000 26,507,000 23,317,000 29,761,000 23,340,000 22,300,000 19,842,000 22,279,000 16,505,000 12,398,000 14,891,000 22,592,000 15,140,000 20,514,000 18,429,000 18,538,000 16,463,000 10,118,000 8,365,000 7,884,000 12,719,000 10,128,000 11,571,000 9,834,000 22,530,000 18,883,000 23,089,000 12,124,000 12,826,000 28,954,000 22,654,000        
        accrued employee compensation and related benefits
      		57,632,000 92,913,000 80,263,000 67,594,000 52,774,000 80,536,000 77,430,000 64,665,000 91,353,000 94,630,000 74,905,000 66,646,000 80,159,000 72,187,000 57,738,000 50,272,000 82,569,000 79,266,000 67,512,000 62,209,000 56,860,000 51,879,000 52,994,000 48,827,000 70,738,000 70,420,000 64,840,000 60,788,000 90,248,000 82,551,000 71,585,000 61,276,000 70,980,000 66,224,000 80,466,000 68,863,000        
        total current liabilities
      		762,478,000 808,072,000 827,588,000 827,100,000 741,573,000 392,125,000 324,402,000 302,986,000 327,771,000 334,983,000 295,396,000 288,164,000 316,129,000 297,398,000 288,016,000 263,893,000 307,914,000 696,970,000 658,465,000 702,248,000 295,356,000 309,052,000 281,759,000 268,364,000 529,724,000 512,553,000 469,191,000 595,909,000 622,310,000 496,746,000 347,067,000 368,020,000 459,475,000 406,016,000 356,357,000 342,448,000 323,828,000 316,811,000 316,895,000 343,913,000 381,548,000 71,012,507  
        long-term debt obligations
      		285,160,000 345,185,000 349,031,000 348,489,000 549,223,000 549,624,000 604,287,000 605,432,000 604,753,000 568,543,000 568,163,000 567,951,000 520,201,000 518,067,000 518,249,000 459,792,000 455,810,000 9,849,000 10,797,000 431,033,000 646,369,000 642,298,000 637,109,000 639,189,000 315,561,000 260,330,000 272,887,000 174,376,000 141,850,000 139,538,000 108,090,000 50,413,000 63,651,000 61,958,000 71,853,000 69,741,000 76,068,000 75,215,000 90,938,000 83,266,000 96,058,000   
        long-term contingent consideration
      		43,141,000 42,045,000 40,641,000 39,662,000                                        
        deferred tax liabilities
      		6,812,000 9,590,000 10,096,000 11,392,000 10,626,000 10,915,000 11,843,000 10,842,000 10,974,000 11,567,000 9,929,000 8,924,000 8,627,000 8,516,000 6,525,000 7,661,000 7,879,000 7,728,000 8,312,000 10,462,000 8,151,000 8,915,000 28,362,000 30,106,000 25,994,000 32,219,000 16,126,000 108,766,000 73,143,000 68,189,000              
        long-term operating lease liabilities
      		46,696,000 48,327,000 43,075,000 42,777,000 40,327,000 40,105,000 44,078,000 43,512,000 43,724,000 45,388,000 25,192,000 27,229,000 28,782,000 29,548,000 28,236,000 31,857,000 30,876,000 35,919,000 38,688,000 42,723,000 42,332,000 42,221,000 43,124,000 42,388,000 43,369,000 46,027,000 44,724,000 47,377,000 47,227,000               
        long-term employee compensation and related benefits
      		13,105,000 13,574,000 13,543,000 13,651,000 13,039,000 12,847,000 14,867,000 16,392,000 17,062,000 17,254,000 15,894,000 16,720,000 16,134,000 16,804,000 17,509,000 17,917,000 18,779,000 19,105,000 18,173,000 18,396,000 19,010,000 20,628,000 23,109,000 22,398,000 21,186,000 22,797,000 25,838,000 26,986,000 22,551,000 25,264,000 30,315,000 29,328,000 29,090,000 28,177,000 33,957,000 33,102,000        
        long-term derivative liabilities
      		93,254,000 83,904,000 64,515,000 48,093,000 37,226,000 51,819,000 84,157,000 105,409,000 104,920,000 45,569,000 53,303,000 53,705,000 41,285,000 85,675,000 83,145,000 134,090,000 170,660,000   200,000 148,283,000 121,940,000 59,588,000                     
        other long-term liabilities
      		54,379,000 55,369,000 51,864,000 52,699,000 47,294,000 44,478,000 47,040,000 44,899,000 48,092,000 47,729,000 46,260,000 45,628,000 46,270,000 45,849,000 42,385,000 47,192,000 49,770,000 49,905,000 52,396,000 46,954,000 46,324,000 49,740,000 6,792,000 12,684,000 14,624,000 15,380,000 13,921,000 15,095,000 16,577,000 22,635,000 25,464,000 33,488,000 183,978,000 69,084,000 74,404,000 75,666,000 37,759,000 39,487,000 27,170,000 29,609,000 31,809,000   
        total liabilities
      		1,305,025,000 1,406,066,000 1,400,353,000 1,383,863,000 1,524,448,000 1,186,131,000 1,211,914,000 1,210,646,000 1,238,065,000 1,151,935,000 1,103,945,000 1,100,947,000 1,067,547,000 1,087,149,000 1,065,915,000 1,054,242,000 1,125,029,000 906,306,000 890,911,000 1,356,052,000 1,303,412,000 1,292,522,000 1,170,956,000 1,169,477,000 1,061,728,000 1,028,080,000 1,014,659,000 1,138,331,000 1,112,738,000 1,045,963,000 825,688,000 814,102,000 885,894,000 688,577,000 688,704,000 690,165,000 635,719,000 635,722,000 680,073,000 701,034,000 792,477,000 79,261,127  
        commitments and contingencies
      		                                           
        shareholders’ equity:
      		                                           
        ordinary shares, £1.00 par value: unlimited shares authorized; 55,537,746 shares issued and 54,901,316 shares outstanding as of march 31, 2026; 55,535,181 shares issued and 54,649,085 shares outstanding as of december 31, 2025
      		84,564,000                                           
        additional paid-in capital
      		2,254,756,000 2,254,980,000 2,245,024,000 2,234,777,000 2,224,578,000 2,220,658,000 2,212,932,000 2,204,580,000 2,192,676,000 2,189,517,000 2,180,661,000 2,169,346,000 2,162,928,000 2,157,724,000 2,143,762,000 2,133,258,000 2,121,098,000 2,117,961,000 2,107,391,000 1,779,113,000 1,770,407,000 1,768,156,000 1,758,468,000 1,750,798,000 1,739,873,000 1,734,870,000 1,725,482,000 1,717,220,000 1,707,117,000 1,705,111,000 1,750,886,000 1,744,262,000 1,738,044,000 1,735,048,000 1,731,565,000 1,726,235,000 1,721,238,000 1,719,893,000 1,751,466,000 1,756,210,000 1,750,863,000 466,462,256  
        accumulated other comprehensive income
      		-3,401,000 7,330,000 5,508,000 8,113,000          -48,119,000    -7,177,000 3,179,000 23,075,000 1,938,000 27,809,000        -24,476,000 -245,000 -2,633,000 54,910,000 45,313,000 38,469,000 870,000        
        accumulated deficit
      		-1,123,427,000 -1,145,721,000 -1,176,627,000 -1,203,411,000 -1,230,572,000 -903,250,000 -959,141,000 -992,094,000 -1,008,427,000 -966,484,000 -982,823,000 -975,505,000 -976,660,000 -984,030,000 -985,691,000 -878,347,000 -894,791,000 -897,784,000 -879,655,000 -837,418,000 -782,100,000 -752,402,000 -472,576,000 -457,804,000 -369,811,000 -406,755,000 -263,525,000 -295,643,000 -266,428,000 -251,579,000 -40,932,000 -33,755,000            
        treasury shares at cost, 636,430 ordinary shares as of march 31, 2026; 886,096 ordinary shares as of december 31, 2025
      		-1,166,000                                           
        total shareholders’ equity
      		1,211,326,000 1,199,987,000                                          
        total liabilities and shareholders’ equity
      		2,516,351,000 2,606,053,000                                          
        restricted cash
      		     294,698,000 320,210,000 303,884,000 306,492,000 311,368,000 298,781,000 311,425,000 308,618,000 301,446,000 275,165,000 297,747,000 313,647,000                           
        ordinary shares, £1.00 par value: unlimited shares authorized; 55,535,181 shares issued and 54,649,085 shares outstanding as of december 31, 2025; 54,437,670 shares issued and 54,348,542 shares outstanding as of december 31, 2024
      		 84,564,000                                          
        treasury shares at cost, 886,096 ordinary shares as of december 31, 2025; 89,128 ordinary shares as of december 31, 2024
      		 -1,166,000                                          
        liabilities and stockholders’ equity
      		                                           
        stockholders’ equity:
      		                                           
        ordinary shares, £1.00 par value: unlimited shares authorized; 55,503,264 shares issued and 54,605,279 shares outstanding at september 30, 2025; 54,437,670 shares issued and 54,348,542 shares outstanding at december 31, 2024
      		  84,520,000                                         
        treasury stock
      		  -1,195,000 -1,161,000 -1,426,000 -136,000 -156,000 -195,000 -481,000 -55,000 -56,000 -95,000 -319,000 -375,000 -380,000 -397,000 -619,000 -650,000 -671,000 -705,000 -798,000 -1,034,000 -1,053,000 -1,057,000 -1,090,000 -1,263,000 -1,282,000 -1,292,000 -1,321,000 -1,462,000 -28,000 -109,000 -375,000 -133,000 -2,329,000 -2,431,000 -2,652,000 -4,500,000    -250,884,706  
        total stockholders’ equity
      		  1,157,230,000 1,122,839,000 1,034,298,000 1,320,258,000 1,310,044,000 1,242,542,000 1,221,537,000 1,277,628,000 1,225,472,000 1,240,608,000 1,227,341,000 1,207,624,000 1,146,963,000 1,282,003,000 1,291,854,000 1,294,645,000 1,312,498,000 1,040,470,000 1,065,757,000 1,118,829,000 1,350,792,000 1,333,186,000 1,392,708,000 1,383,717,000 1,495,282,000 1,483,328,000 1,486,806,000 1,503,738,000 1,784,992,000 1,783,034,000 1,818,982,000 1,815,314,000 1,914,426,000 1,843,520,000 1,734,928,000 1,706,909,000 1,816,887,000 1,823,831,000 1,825,233,000 278,385,949 76,000 
        total liabilities and stockholders’ equity
      		  2,557,583,000 2,506,702,000 2,558,746,000 2,506,389,000 2,521,958,000 2,453,188,000 2,459,602,000 2,429,563,000 2,329,417,000 2,341,555,000 2,294,888,000 2,294,773,000 2,212,878,000 2,336,245,000 2,416,883,000 2,200,951,000 2,203,409,000 2,396,522,000 2,369,169,000 2,411,351,000 2,521,748,000 2,502,663,000 2,454,436,000 2,411,797,000 2,509,941,000 2,621,659,000 2,599,544,000 2,549,701,000 2,610,680,000 2,597,136,000 2,704,876,000 2,503,891,000 2,603,130,000 2,533,685,000 2,370,647,000 2,342,631,000 2,496,960,000 2,524,865,000 2,617,710,000 357,647,076 76,000 
        ordinary shares, £1.00 par value: unlimited shares authorized; 55,498,718 shares issued and 54,590,282 shares outstanding at june 30, 2025; 54,437,670 shares issued and 54,348,542 shares outstanding at december 31, 2024
      		   84,521,000                                        
        contingent consideration
      		    85,140,000 84,218,000 81,240,000 81,174,000 80,769,000 80,902,000 89,808,000 92,626,000 90,119,000 85,292,000 81,850,000 91,840,000 83,341,000 86,830,000 104,080,000 97,047,000 89,847,000 89,850,000 79,603,000 71,236,000 99,725,000 114,396,000 140,472,000 133,072,000 147,080,000 161,381,000 164,610,000 178,449,000            
        ordinary shares, £1.00 par value: unlimited shares authorized; 55,440,867 shares issued and 54,522,652 shares outstanding at march 31, 2025; 54,437,670 shares issued and 54,348,542 shares outstanding at december 31, 2024
      		    84,446,000                                       
        accumulated other comprehensive loss
      		    -42,728,000 -80,170,000 -26,703,000 -52,819,000 -45,206,000 -27,883,000 -54,801,000 -35,579,000 -41,032,000  -93,104,000 -54,870,000 -16,132,000      -10,385,000 -35,089,000 -52,523,000 -19,392,000 -41,610,000 -13,174,000 -28,713,000        -54,966,000  -25,341,000 -24,905,000 -9,106,000 -2,667,629  
        ordinary shares, £1.00 par value: unlimited shares authorized; 54,437,670 shares issued and 54,348,542 shares outstanding at december 31, 2024; 53,942,151 shares issued and 53,918,222 shares outstanding at december 31, 2023
      		     83,156,000                                      
        liabilities and stockholders' equity
      		                                           
        ordinary shares, £1.00 par value: unlimited shares authorized; 54,405,751 shares issued and 54,300,048 shares outstanding at september 30, 2024; 53,942,151 shares issued and 53,918,222 shares outstanding at december 31, 2023
      		      83,112,000                                     
        ordinary shares, £1.00 par value: unlimited shares authorized; 54,403,904 shares issued and 54,296,008 shares outstanding at june 30, 2024; 53,942,151 shares issued and 53,918,222 shares outstanding at december 31, 2023
      		       83,070,000                                    
        property, plant and equipment
      		        152,237,000 154,181,000 149,302,000 149,568,000 149,060,000 147,187,000 139,162,000 143,312,000 147,957,000 150,066,000 152,728,000 157,415,000 157,892,000 163,805,000 190,509,000 185,670,000 183,534,000 181,354,000 179,507,000 185,098,000 185,947,000 191,400,000 188,460,000 186,156,000 191,701,000 192,359,000 213,769,000 211,164,000 205,121,000 223,842,000 245,120,000 245,006,000 253,750,000 40,574,394  
        ordinary shares, £1.00 par value: unlimited shares authorized; 54,295,837 shares issued and 54,148,808 shares outstanding at march 31, 2024; 53,942,151 shares issued and 53,918,222 shares outstanding at december 31, 2023
      		        82,975,000                                   
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,942,151 shares issued and 53,918,222 shares outstanding at december 31, 2023; 53,851,979 shares issued and 53,564,664 shares outstanding at december 31, 2022
      		         82,533,000                                  
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,903,564 shares issued and 53,860,644 shares outstanding at september 30, 2023; 53,851,979 shares issued and 53,564,664 shares outstanding at december 31, 2022
      		          82,491,000                                 
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,903,564 shares issued and 53,830,387 shares outstanding at june 30, 2023; 53,851,979 shares issued and 53,564,664 shares outstanding at december 31, 2022
      		           82,441,000                                
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,854,241 shares issued and 53,763,715 shares outstanding at march 31, 2023; 53,851,979 shares issued and 53,564,664 shares outstanding at december 31, 2022
      		            82,424,000                               
        current derivative assets
      		             1,333,000 760,000 2,520,000 82,000 106,629,000 95,928,000 105,371,000                        
        current derivative liabilities
      		             5,886,000 3,572,000 3,232,000 1,928,000 183,109,000 151,388,000 174,866,000                        
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,851,979 shares issued and 53,564,664 shares outstanding at december 31, 2022; 53,761,510 shares issued and 53,263,297 shares outstanding at december 31, 2021
      		             82,424,000                              
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,814,279 shares issued and 53,522,857 shares outstanding at september 30, 2022; 53,761,510 shares issued and 53,263,297 shares outstanding at december 31, 2021
      		              82,376,000                             
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,810,418 shares issued and 53,506,408 shares outstanding at june 30, 2022; 53,761,510 shares issued and 53,263,297 shares outstanding at december 31, 2021
      		               82,359,000                            
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,763,500 shares issued and 53,435,821 shares outstanding at march 31, 2022; 53,761,510 shares issued and 53,263,297 shares outstanding at december 31, 2021
      		                82,298,000                           
        assets held for sale
      		                    67,475,000 70,539,000           13,652,000 13,628,000 14,117,000 13,859,000 17,622,000       
        liabilities held for sale
      		                    27,118,000 29,679,000                      
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,761,510 shares issued and 53,263,297 shares outstanding at december 31, 2021; 49,447,473 shares issued and 48,655,863 shares outstanding at december 31, 2020
      		                 82,295,000                          
        ordinary shares, £1.00 par value: unlimited shares authorized; 53,731,820 shares issued and 53,221,234 shares outstanding at september 30, 2021; 49,447,473 shares issued and 48,655,863 shares outstanding at december 31, 2020
      		                  82,254,000                         
        litigation provision liability
      		                   6,989,000 7,740,000 7,878,000 11,510,000 11,611,000 11,545,000 24,378,000 31,500,000 36,750,000 42,000,000 132,210,000              
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,522,582 shares issued and 48,983,280 shares outstanding at june 30, 2021; 49,447,473 shares issued and 48,655,863 shares outstanding at december 31, 2020
      		                   76,405,000                        
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,454,726 shares issued and 48,844,543 shares outstanding at march 31, 2021; 49,447,473 shares issued and 48,655,863 shares outstanding at december 31, 2020
      		                    76,310,000                       
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,447,473 shares issued and 48,655,863 shares outstanding at december 31, 2020; 49,411,016 shares issued and 48,443,830 shares outstanding at december 31, 2019
      		                     76,300,000                      
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,402,628 shares issued and 48,596,417 shares outstanding at september 30, 2020; 49,411,016 shares issued and 48,443,830 shares outstanding at december 31, 2019
      		                      76,338,000                     
        long-term derivative liability
      		                       71,501,000                    
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,476,223 shares issued and 48,667,203 shares outstanding at june 30, 2020; 49,411,016 shares issued and 48,443,830 shares outstanding at december 31, 2019
      		                       76,338,000                    
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,413,610 shares issued and 48,578,610 shares outstanding at march 31, 2020; 49,411,016 shares issued and 48,443,830 shares outstanding at december 31, 2019
      		                        76,259,000                   
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,411,016 shares issued and 48,443,830 shares outstanding at december 31, 2019; 49,323,418 shares issued and 48,205,783 shares outstanding at december 31, 2018
      		                         76,257,000                  
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,380,570 shares issued and 48,399,097 shares outstanding at september 30, 2019; 49,323,418 shares issued and 48,205,783 shares outstanding at december 31, 2018
      		                          76,217,000                 
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,380,284 shares issued and 48,391,071 shares outstanding at june 30, 2019; 49,323,418 shares issued and 48,205,783 shares outstanding at december 31, 2018
      		                           76,217,000                
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,329,119 shares issued and 48,318,226 shares outstanding at march 31, 2019; 49,323,418 shares issued and 48,205,783 shares outstanding at december 31, 2018
      		                            76,151,000               
        assets of discontinued operations
      		                                257,140,000 250,689,000          
        liabilities of discontinued operations
      		                                84,993,000 78,075,000          
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,323,418 shares issued and 48,205,783 shares outstanding at december 31, 2018; 48,290,276 shares issued and 48,287,346 shares outstanding at december 31, 2017
      		                             76,144,000              
        deferred income taxes liability
      		                              150,142,000 154,404,000 149,700,000 123,342,000 152,133,000 169,208,000 166,960,000 172,541,000 213,062,000 212,351,000 250,531,000   
        ordinary shares, £1.00 par value: unlimited shares authorized; 48,693,535 shares issued and 48,680,054 shares outstanding at september 30, 2018; 48,290,276 shares issued and 48,287,346 shares outstanding at december 31, 2017
      		                              75,311,000             
        ordinary shares, £1.00 par value: unlimited shares authorized; 48,661,493 shares issued and 48,584,123 shares outstanding at june 30, 2018; 48,290,276 shares issued and 48,287,346 shares outstanding at december 31, 2017
      		                               75,269,000            
        ordinary shares, £1.00 par value: unlimited shares authorized; 48,627,730 shares issued and 48,428,600 shares outstanding at march 31, 2018; 48,290,276 shares issued and 48,287,346 shares outstanding at december 31, 2017
      		                                75,224,000           
        retained deficit
      		                                -48,821,000    -3,304,000       
        ordinary shares, £1.00 par value: unlimited shares authorized; 48,290,276 shares issued and 48,287,346 outstanding at december 31, 2017; 48,156,690 shares issued and 48,028,413 outstanding at december 31, 2016
      		                                 74,750,000          
        accumulated loss
      		                                 -39,664,000          
        ordinary shares, £1.00 par value: unlimited shares authorized; 48,250,361 shares issued and 48,200,257 shares outstanding at september 30, 2017; 48,156,690 shares issued and 48,028,413 shares outstanding at december 31, 2016
      		                                  74,697,000         
        retained earnings
      		                                  72,024,000 44,194,000   15,224,000 16,793,000 7,836,000 65,154,622 1,000 
        ordinary shares, £1.00 par value: unlimited shares authorized; 48,215,885 shares issued and 48,163,627 shares outstanding at june 30, 2017; 48,156,690 shares issued and 48,028,413 shares outstanding at december 31, 2016
      		                                   74,652,000        
        prepaid and refundable income taxes
      		                                    60,367,000 60,615,000      
        accrued liabilities
      		                                    68,416,000 75,567,000 62,046,000 63,227,000 80,534,000 55,407,502  
        income taxes payable
      		                                    26,682,000 22,340,000 16,655,000 20,125,000 26,951,000   
        accrued employee compensation and related benefits liability
      		                                    81,320,000 78,302,000 80,028,000 70,539,000 79,669,000   
        long-term employee compensation and related benefits liability
      		                                    31,104,000 31,668,000 32,008,000 31,895,000 32,531,000   
        ordinary shares, £1.00 par value: unlimited shares authorized; 48,184,737 shares issued and 48,124,731shares outstanding at march 31, 2017; 48,156,690 shares issued and 48,028,413 shares outstanding at december 31, 2016
      		                                    74,612,000       
        short-term investments
      		                                       6,999,000 6,988,000 6,999,067  
        ordinary shares, £1.00 par value: unlimited authorized; 48,156,690 shares issued and 48,028,413 outstanding at december 31, 2016; 48,868,305 shares issued and outstanding at december 31, 2015
      		                                     74,578,000      
        common stock
      		                                           
        accumulated other comprehensive
      		                                     -68,487,000      
        accumulated earnings
      		                                     -14,575,000      
        prepaid taxes
      		                                      49,854,000 47,293,000 51,354,000   
        ordinary shares, £1.00 par value: unlimited shares authorized; 48,924,009 and 48,868,305 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively
      		                                      75,538,000     
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,071,640 and 48,868,305 shares issued and outstanding at june 30, 2016 and december 31, 2015, respectively
      		                                       75,733,000    
        ordinary shares, £1.00 par value: unlimited shares authorized; 49,008,015 and 48,868,305 shares issued and outstanding at march 31, 2016 and december 31, 2015, respectively
      		                                        75,640,000   
        current assets
      		                                           
        deferred tax assets current
      		                                         4,381,475  
        other current assets
      		                                         9,746,124  
        investments in equity securities
      		                                         15,062,643  
        deferred tax assets non-current
      		                                         7,122,342  
        current liabilities
      		                                           
        long-term liabilities
      		                                         8,248,620  
        stockholders’ equity
      		                                           
        preferred stock, .01 par value per share...
      		                                           
        common stock, .01 par value per share...
      		                                         321,406  
        receivable from sorin s.p.a.
      		                                          76,000 
        ordinary shares
      		                                           
        redeemable stock
      		                                          75,000 
        cash flows from operating activities
      		                                           
        net income
      		                                          1,000 
        non-cash items included in net income:
      		                                           
        unrealized gain in foreign currency transactions
      		                                          1,000 
        net cash from operating activities
      		                                           
        cash flow from investing activities
      		                                           
        net cash from investing activities
      		                                           
        cash flows from financing activities:
      		                                           
        net cash from financing activities
      		                                           
        effect of exchange rate changes on cash and cash equivalents
      		                                           
        net increase in cash and cash equivalents
      		                                           
        cash and cash equivalents at beginning of period
      		                                           
        cash and cash equivalents at end of period
      		                                           
        supplementary disclosures of non-cash activity in financing:
      		                                           
        issuance of shares resulting in stock subscription receivable
      		                                          75,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2016-09-30 2016-06-30 2016-03-31 2015-10-18 2015-02-20 
                                               
          operating activities:
        		                                       
          net income
        		22,294,000 30,906,000    55,891,000 32,953,000 16,333,000 -41,943,000 16,339,000 -7,318,000 1,155,000 7,370,000   16,444,000 2,993,000    -29,698,000    37,583,000  32,118,000 -29,215,000 -14,849,000 -210,561,000 -7,177,000 15,066,000 13,273,000 -111,688,000 -1,569,000 8,957,000 -40,378,000 -12,673,180 1,000 
          adjustments to reconcile net income to net cash from operating activities:
        		                                       
          remeasurement of contingent consideration to fair value
        		10,655,000 2,393,000 1,755,000 2,787,000 922,000 2,978,000 66,000 405,000 -133,000 4,844,000 -2,818,000 2,507,000 4,827,000 3,442,000 -5,964,000 -23,586,000 -3,773,000 -17,191,000 7,009,000 10,293,000 453,000 10,713,000 14,858,000 -28,751,000 -17,283,000   -20,057,000 9,457,000           
          remeasurement of derivative instruments
        		9,795,000 10,091,000 10,270,000 -8,543,000 -18,717,000 -25,745,000 -12,065,000 867,000 11,598,000 2,819,000 -398,000 949,000 -26,281,000 169,000 -33,727,000 -3,743,000 -1,355,000 19,829,000 -15,402,000 5,923,000 7,268,000 39,739,000 -10,404,000                 
          depreciation
        		8,300,000 7,555,000 7,715,000 6,874,000 6,419,000 6,421,000 6,242,000 6,175,000 6,266,000 6,155,000 6,542,000 6,084,000 5,956,000 5,780,000 5,497,000 5,470,000 5,626,000 6,043,000 6,237,000 6,177,000 6,079,000 6,825,000 8,610,000 6,800,000 6,796,000 7,202,000 7,828,000 7,740,000 7,547,000 7,767,000 8,355,000 8,290,000 8,334,000 9,174,000 10,710,000     
          share-based compensation
        		8,270,000                                       
          amortization of debt issuance costs
        		4,769,000 5,800,000 5,862,000 5,721,000 5,676,000 5,907,000 5,497,000 5,295,000 4,900,000 4,807,000 4,711,000 4,516,000 5,019,000 4,940,000 4,673,000 7,309,000 4,412,000 3,570,000 4,098,000 4,580,000 4,409,000                   
          amortization of intangible assets
        		4,563,000  4,530,000 4,441,000 4,215,000  4,345,000 4,286,000 4,329,000                               
          amortization of operating lease assets
        		2,732,000 2,636,000 2,970,000 3,725,000 4,037,000 1,910,000 2,541,000 1,833,000 2,544,000 3,377,000 2,163,000 2,465,000 2,642,000 3,125,000 2,161,000 2,286,000 2,653,000 4,802,000 3,186,000 3,558,000 5,389,000 4,164,000 3,516,000   3,336,000 2,627,000             
          deferred income tax expense
        		1,824,000 -3,611,000 1,303,000 519,000 2,244,000 -2,298,000 3,537,000 756,000 4,800,000                          2,621,000 -14,127,000 1,282,000   
          impairments of investments
        		1,132,000                                       
          loss on investment revaluation - ceribell, inc.
        		 0 0 1,008,000 2,614,000                                   
          other
        		1,174,000 761,000 1,459,000 957,000 11,000 1,497,000 749,000 1,238,000 -534,000 -1,402,000 2,315,000 382,000 -184,000 1,261,000 -950,000 269,000 1,073,000 -1,227,000 588,000 683,000 673,000 -4,640,000 443,000 3,722,000 1,711,000 3,460,000 -747,000 -655,000 3,354,000 382,000 -959,000 72,000 -1,015,000 1,876,000 3,720,000 1,753,000 3,292,000   
          changes in operating assets and liabilities:
        		                                       
          accounts receivable
        		-14,669,000 -4,875,000 7,842,000 -9,776,000 -3,896,000 -6,365,000 9,027,000 6,407,000 1,991,000 -20,625,000 -7,532,000 -8,265,000 7,558,000 -3,145,000 -790,000 -2,369,000 1,494,000 -7,894,000 -3,187,000 -1,292,000 -3,372,000 -6,605,000 -855,000 41,920,000 24,336,000 -10,754,000 5,710,000 -7,341,000 7,064,000 -9,325,000 8,707,000 12,690,000 9,109,000 -29,827,000 16,134,000 -18,732,000 -8,442,000   
          inventories
        		-1,546,000 2,809,000 -2,062,000 -3,544,000 -2,494,000 7,138,000 -2,957,000 -2,792,000 -8,146,000 4,546,000 -7,585,000 -14,097,000 -11,342,000 -3,108,000 -6,110,000 -6,824,000 -9,637,000 -172,000 3,435,000 4,121,000 -2,900,000 13,544,000 4,069,000 -3,697,000 -12,513,000 7,573,000 -3,897,000 -5,992,000 -8,292,000 -3,025,000 3,663,000 -4,980,000 -6,305,000 18,193,000 -4,128,000 13,935,000 10,800,000   
          other current and non-current assets
        		-4,199,000 -12,044,000 15,042,000 29,103,000 6,437,000 13,196,000 -11,475,000 5,579,000 -8,945,000 18,283,000 5,340,000 -4,483,000 -3,838,000 -4,705,000 9,345,000 4,799,000 -1,953,000 3,595,000 1,746,000 -8,034,000 26,820,000 -24,285,000 -5,097,000 15,437,000 -25,700,000 -8,730,000 5,098,000 24,906,000 -23,377,000 3,768,000 -971,000 905,000 -16,691,000 11,666,000 -7,406,000 294,000 -16,030,000   
          accounts payable and accrued current and non-current liabilities
        		-38,771,000 22,605,000 -2,880,000 -2,655,000 -30,516,000 8,905,000 1,997,000 -9,804,000 -15,576,000 27,274,000 -3,446,000 -26,016,000 21,378,000 1,885,000 13,992,000 -29,344,000 9,957,000 9,994,000 -559,000 5,416,000 -1,858,000 48,624,000 -2,463,000 -45,735,000 -1,349,000 -2,866,000 165,000 -35,513,000 6,384,000 -10,711,000 21,758,000 -9,567,000 5,697,000 -26,175,000 -11,470,000     
          taxes payable
        		1,713,000 9,984,000 -12,678,000 -6,831,000 5,934,000 8,223,000 1,808,000 -6,067,000 6,887,000 1,014,000 3,609,000 1,766,000 972,000 3,150,000 -1,888,000 -593,000 709,000 -4,893,000 2,505,000 5,828,000 -3,337,000 4,211,000 1,535,000   5,925,000 28,641,000             
          litigation provision liability
        		-2,820,000 -4,126,000 4,341,000 -1,529,000 226,000 -3,008,000 152,000 -1,104,000 6,235,000 -16,266,000 4,392,000 2,997,000 -10,254,000 -14,729,000 10,235,000 1,033,000 -3,097,000 -691,000 -19,777,000 25,806,000 -2,078,000 -10,114,000 -2,964,000 -5,585,000 -115,609,000 17,128,000              
          snia environmental liability
        		 1,738,000 1,745,000 1,677,000 360,393,000                                   
          net cash from operating activities
        		15,216,000 82,397,000 85,057,000 62,920,000 23,966,000 78,707,000 50,994,000 43,356,000 9,981,000 53,958,000 18,136,000 -17,937,000 20,757,000 18,703,000 35,638,000 -10,243,000 25,823,000 33,480,000 23,953,000 25,631,000 19,480,000 36,985,000 8,657,000 -19,019,000 -106,045,000 2,866,000 -76,587,000 -19,395,000 1,974,000 20,890,000 51,063,000 28,143,000 20,393,000 17,674,000 36,764,000 2,984,000 9,600,000   
          capital expenditures
        		-14,290,000 -32,233,000 -22,880,000 -15,147,000 -10,790,000 -10,406,000 -18,147,000 0 -6,398,000 -12,919,000 -8,718,000 -5,659,000 -7,685,000 -9,134,000 -6,041,000 -6,127,000 -5,215,000 -7,585,000 -3,271,000 -6,402,000 -8,220,000 -6,579,000 -10,490,000 -9,358,000 -8,597,000 -7,890,000 -6,005,000 0 -5,741,000 -12,898,000 -11,868,000 -7,385,000 -5,846,000 0 -10,945,000 -7,690,000 -8,137,000   
          free cash flows
        		926,000 50,164,000 62,177,000 47,773,000 13,176,000 68,301,000 32,847,000 43,356,000 3,583,000 41,039,000 9,418,000 -23,596,000 13,072,000 9,569,000 29,597,000 -16,370,000 20,608,000 25,895,000 20,682,000 19,229,000 11,260,000 30,406,000 -1,833,000 -28,377,000 -114,642,000 -5,024,000 -82,592,000 -19,395,000 -3,767,000 7,992,000 39,195,000 20,758,000 14,547,000 17,674,000 25,819,000 -4,706,000 1,463,000   
          investing activities:
        		                                       
          purchases of property, plant, and equipment
        		-14,290,000 -32,233,000 -22,880,000 -15,147,000 -10,790,000 -10,406,000 -18,147,000                                 
          net cash from investing activities
        		-14,580,000 -30,259,000 -23,057,000 -8,968,000 -10,628,000 -10,708,000 -18,520,000 -12,569,000 -6,363,000 -12,138,000 -10,054,000 -6,655,000 -11,484,000 -10,953,000 -5,831,000 -16,148,000 -5,482,000 -3,631,000 -6,180,000 56,573,000 -9,858,000 -8,507,000 -10,671,000 -11,581,000 -11,085,000 -10,771,000 -8,065,000 -16,813,000 -5,641,000 -13,148,000 -14,218,000 -9,838,000 -83,352,000 -11,058,000 -13,719,000 -7,101,000 -8,948,000   
          financing activities:
        		                                       
          repayment of long-term debt obligations
        		-95,938,000 -64,114,000 -6,563,000 -205,875,000 -4,375,000 -4,372,000 -4,424,000 -4,375,000 -234,375,000 -5,563,000 -4,253,000 -9,933,000 -1,875,000 -2,757,000 -220,000,000   -860,000 -450,109,000   -705,000 -106,000   -11,880,000 -205,000   -11,537,000 -50,000 -11,986,000 -254,000 -11,140,000 -288,000 -10,497,000 -569,000   
          net cash from financing activities
        		-94,245,000 -62,884,000 -9,373,000 -208,982,000 -4,421,000 -3,444,000 -3,282,000 -11,870,000 37,147,000 -5,018,000 -4,277,000 36,014,000 -5,235,000 -1,657,000 73,230,000 -6,320,000 214,877,000 -3,300,000 -164,096,000 -5,759,000 -8,328,000 -5,171,000 -3,770,000 136,604,000 183,093,000 -7,160,000 116,684,000 29,468,000 7,589,000 -39,438,000 -3,837,000 -31,120,000 32,047,000  -23,415,000 -19,107,000 -27,069,000   
          effect of exchange rate changes on cash, cash equivalents, and restricted cash
        		-2,237,000 219,000 -186,000 10,231,000 5,964,000 -7,575,000 4,263,000                                 
          net increase in cash, cash equivalents, and restricted cash
        		-95,846,000 -10,527,000 52,441,000 -144,799,000 14,881,000 56,980,000 33,455,000                                 
          cash, cash equivalents, and restricted cash at beginning of period
        		635,552,000 0 0 0 723,556,000 0 0                                 
          cash and cash equivalents at end of period
        		539,706,000                 26,146,000 -147,540,000 76,847,000 252,539,000 25,021,000 -4,738,000 106,726,000 125,823,000 -14,176,000 30,802,000 -6,265,000 50,776,000 -32,744,000 32,568,000 -17,584,000 64,964,000 28,457,000 -254,000 -23,582,000 87,468,000   
          supplemental noncash investing and financing transactions:
        		                                       
          capital expenditures included in accounts payable
        		10,461,000                                       
          amortization
        		         6,343,000 6,382,000 6,392,000 6,355,000 6,228,000 6,053,000 6,452,000 6,465,000 6,512,000 6,652,000 6,654,000 6,699,000 8,966,000 9,685,000 9,394,000 10,267,000 10,685,000 11,146,000 9,228,000 9,316,000 9,142,000 9,443,000 9,807,000 8,802,000 10,436,000 11,775,000     
          gain on sale of asset
        		                                       
          loss on debt extinguishment
        		 0 0   0 0 0 25,482,000         0                      
          impairment of investments
        		     0                                  
          impairment of long-lived assets
        		                                       
          acs inventory obsolescence adjustment
        		                                       
          proceeds from sale of investment
        		                                       
          proceeds from asset sales
        		                11,000    162,000    834,000 756,000 104,000 301,000 100,000 348,000 650,000 13,099,000 123,000 589,000      
          purchases of investments
        		                             -770,000          
          shares repurchased from employees for minimum tax withholding
        		 -805,000 256,000   -368,000 54,000 -7,809,000 -316,000 -508,000 -1,154,000 -4,264,000 -1,577,000 -121,000 -327,000 -7,149,000 -1,074,000 -696,000 -1,174,000 -7,332,000 -3,740,000 -324,000 -100,000 -1,180,000 -3,997,000 -881,000 -469,000 -1,108,000 -4,606,000 -3,052,000 -1,429,000         
          proceeds from exercise of stock options
        		 2,000    1,313,000 1,346,000                   41,000 8,000 204,000 119,000 1,000 1,446,000 1,124,000 1,607,000 1,752,000      
          proceeds from long-term debt obligations
        		     0 0 0 335,513,000 0 0   0 289,205,000 0 218,342,000     0 0 724,000,000 162,899,000 3,670,000 139,713,000 50,804,000 2,973,000 43,570,000          
          payment of debt extinguishment costs
        		     0 0 0 -38,953,000                               
          purchase of capped calls
        		     0 0 0 -31,637,000                               
          proceeds from unwind of capped calls
        		     0 0 0 22,523,000                               
          payment of contingent consideration
        		     0 0 0 -13,750,000         0 -862,000 0 -4,387,000 -3,158,000 -3,610,000 -646,000 -4,604,000 -966,000              
          payment of debt issuance costs
        		     -8,000 -233,000 -3,805,000 -1,893,000      -431,000 -435,000 -2,426,000                       
          cash, cash equivalents, and restricted cash at end of period
        		 -10,527,000 52,441,000 -144,799,000 738,437,000 56,980,000 33,455,000                                 
          stock-based compensation
        		  9,947,000 9,174,000 7,783,000 6,949,000 8,559,000 8,199,000 10,226,000 8,283,000 11,779,000 5,711,000 10,579,000 12,317,000 10,727,000 11,509,000 10,256,000 9,990,000 11,122,000 9,916,000 9,536,000 8,244,000 7,811,000 9,991,000 9,043,000 8,426,000 8,531,000 8,724,000 6,872,000 5,536,000 7,167,000 7,540,000 6,680,000 4,801,000 4,768,000 4,691,000 6,116,000   
          proceeds from investments
        		  0                                     
          supplemental noncash investing and financing transaction:
        		                                       
          asset obtained in exchange for finance lease obligation
        		                                       
          net loss
        		   27,161,000 -327,322,000              -42,237,000   -279,826,000 -14,772,000                 
          adjustments to reconcile net loss to net cash from operating activities:
        		                                       
          impairment of investment in shiratronics, inc.
        		                                       
          gain on investment revaluation - ceribell, inc.
        		                                       
          impairment of goodwill
        		             0                          
          purchase of investments
        		     -296,000 -472,000   66,000 -1,161,000 -273,000 -5,136,000 -2,024,000 -147,000 -503,000 -278,000 -133,000 -1,423,000 -297,000 -1,800,000  -7,000                 
          acquisitions, net of cash acquired
        		                         0 0   172,000 0         
          proceeds from deferred consideration from sale of heart valves, net of working capital adjustments
        		             -1,000                          
          repayments of short-term borrowings
        		         -73,000 73,000 0 -1,974,000                           
          purchases of property, plant and equipment
        		        -6,398,000 -12,919,000 -8,718,000 -5,659,000 -7,685,000 -9,134,000 -6,041,000 -6,127,000 -5,215,000 -7,585,000 -3,271,000 -6,402,000 -8,220,000 -6,579,000 -10,490,000 -9,358,000 -8,597,000 -7,890,000 -6,005,000             
          effect of exchange rate changes on cash, cash equivalents and restricted cash
        		        -2,954,000 8,348,000 -5,443,000 -20,000 3,302,000 3,246,000 -3,527,000 -2,904,000 -826,000                       
          net increase in cash, cash equivalents and restricted cash
        		        37,811,000 45,150,000 -1,638,000 11,402,000 7,340,000 9,339,000 99,510,000 -35,615,000 234,392,000                       
          cash, cash equivalents and restricted cash at beginning of period
        		        577,872,000 0 0 0 515,618,000 0 0 0 207,992,000                       
          cash, cash equivalents and restricted cash at end of period
        		        615,683,000 45,150,000 -1,638,000 11,402,000 522,958,000 9,339,000 99,510,000 -35,615,000 442,384,000                       
          deferred tax expense
        		             432,000 332,000   3,194,000 -1,699,000 1,320,000 37,000 -3,841,000 -5,038,000     13,904,000 1,993,000           
          impairment of disposal group and loss on sale
        		                                       
          proceeds from sale of heart valves, net of cash disposed
        		                 2,701,000 -1,515,000                     
          proceeds from sale of respicardia investment and loan
        		                 0 0                     
          debt issuance costs
        		                 -575,000 -1,499,000   -3,324,000 -442,000   0 -107,000 -1,938,000 -1,750,000           
          proceeds from issuance of ordinary shares
        		                 -1,623,000                      
          payment of make-whole premium on long-term debt obligations
        		                 0                      
          acquisition, net of cash acquired
        		              0                         
          proceeds from share issuances under espp
        		          1,036,000    0    0   1,681,000 -1,000   1,894,000 0             
          non-cash items included in net income:
        		                                       
          proceeds from short term borrowings
        		                      0 602,000 46,115,000               
          repayments of short term borrowings
        		                      0                 
          purchase of capped call
        		                     0 0                 
          closing adjustment payment for sale of crm business
        		                     0 0 0 -14,891,000               
          non-cash items included in net loss:
        		                                       
          remeasurement of respicardia investment and loan
        		                  -2,000 0 -4,640,000                   
          non-cash items included in net income
        		                                       
          effect of exchange rate changes on cash and cash equivalents
        		                 -403,000 -1,217,000 402,000 -1,587,000 1,714,000 1,046,000 722,000 -1,277,000 889,000 -1,230,000 475,000 -350,000 -1,048,000 -440,000 -4,769,000 2,261,000 547,000 116,000 -358,000 1,272,000   
          net increase in cash and cash equivalents
        		                 26,146,000 -147,540,000 76,847,000 -293,000 25,021,000 -4,738,000 106,726,000 64,686,000 -14,176,000   3,572,000 -32,744,000 32,568,000 -17,584,000 -28,651,000 28,457,000 -254,000 -23,582,000 -25,145,000   
          cash and cash equivalents at beginning of period
        		                 0 0 0 252,832,000 0 0 0 61,137,000 0 0 0 47,204,000 0 0 0 93,615,000 0 0 0 112,613,000   
          loans to investees
        		                     -441,000 0                 
          change in short-term borrowing
        		                   712,000 -643,000 171,000 489,000 945,000 -2,477,000 985,000 -4,528,000 -8,706,000 11,061,000 536,000 -13,310,000 -33,474,000 15,503,000 30,450,000      
          impairment of disposal group
        		                                       
          amortization of income taxes payable on inter-company transfers of property
        		                            1,411,000 9,215,000 -1,011,000 3,187,000 1,979,000 7,953,000      
          gain on acquisition
        		                                       
          purchases of intangible assets
        		                         -103,000 -2,164,000             
          proceeds from the sale of crm business, net of cash disposed
        		                                       
          proceeds from short-term borrowing
        		                             0 0 220,000,000 20,000,000 0      
          repayment of short-term borrowing
        		                             -20,000,000 -50,000,000         
          share repurchases under share repurchase program
        		                                       
          payment of deferred consideration - acquisition of caisson interventional, llc
        		                             1,079,000 0         
          impairment of intangible assets
        		                         89,000,000 0             
          restructuring reserve
        		                      -277,000 -474,000 -443,000 19,000 -1,293,000 -567,000 -4,906,000 6,136,000 84,000 -621,000 905,000 -1,804,000 -1,842,000 -5,208,000 22,011,000   
          deferred tax benefit
        		                        -22,884,000 145,000              
          purchase of investment
        		                        -3,000,000  0             
          impairment of property, plant and equipment
        		                             50,000 37,000 22,000 458,000 1,398,000      
          losses from equity method investments
        		                             17,000 0 265,000 1,573,000 1,534,000      
          gain on acquisitions
        		                             0 0         
          impairment of discontinued operations
        		                                       
          proceeds from the sale of crm business franchise, net of cash disposed
        		                                       
          amortization of income taxes payable on intercompany transfers of property
        		                          28,000             
          net decrease in cash and cash equivalents
        		                                       
          purchases of property, plant and equipment and other
        		                            -5,741,000 -12,898,000 -11,868,000 -7,385,000 -5,846,000       
          purchases of short-term investments
        		                                       
          maturities of short-term investments
        		                                  7,025,000 26,000 7,000,000   
          repayment of trade receivable advances
        		                                  -2,222,000 -5,550,000 -16,076,000   
          deferred income tax benefit
        		                              -3,579,000 -8,987,000 -922,000       
          proceeds from the sale of crm business franchise
        		                              0         
          proceeds from sale of cost-method investment
        		                                       
          loans to equity method investees
        		                                       
          gain on acquisition of imthera medical, inc.
        		                                -11,484,000       
          acquisition of imthera medical, inc., net of cash acquired
        		                                -77,629,000       
          loans to equity-method investees
        		                                       
          deferred income tax (benefit) expense
        		                                       
          gain on acquisition of caisson interventional, llc
        		                                 0      
          impairment of cost-method investments
        		                                       
          purchases of property, plant, equipment and other
        		                                       
          acquisition of caisson interventional, llc, net of cash acquired
        		                                 0      
          purchases of cost and equity method investments
        		                                 -1,046,000      
          loans to cost and equity method investees
        		                                 -498,000      
          cash obtained in the merger
        		                                       
          share repurchases
        		                                       
          net cash from (used) in financing activities
        		                                       
          proceeds from sale of cost method investment
        		                                       
          cash flows from operating activities:
        		                                       
          income from investments
        		                                       
          cash flow from investing activities:
        		                                       
          purchase of short-term investments
        		                                  -26,000 -37,000 -6,991,000   
          purchase of property, plant and equipment and other
        		                                  -10,945,000 -7,690,000 -8,137,000   
          intangible assets purchases
        		                                  -1,105,000 -9,000 -820,000   
          purchases of equity and cost method investments
        		                                       
          cash flows from financing activities:
        		                                       
          short-term borrowing
        		                                  1,619,000 -9,642,000 14,083,000   
          short-term repayments
        		                                  -19,851,000 4,385,000 -24,425,000   
          proceeds from exercise of options for common stock
        		                                  3,166,000     
          realized excess tax benefits - stock-based compensation
        		                                  339,000 164,000 705,000   
          purchase of ordinary stock
        		                                       
          purchase of treasury stock
        		                                       
          cash settlement of compensation-based stock units
        		                                       
          supplementary disclosures of cash flow information:
        		                                       
          cash paid for interest
        		                                  3,632,000 1,208,000 602,000   
          cash paid for income taxes
        		                                  15,040,000 20,304,000 3,603,000   
          supplementary disclosure of a non-cash operating transaction:
        		                                       
          decrease to apic related to share-based compensation options cashed out
        		                                       
          increase to liabilities related to share-based compensation options cashed-out
        		                                       
          supplementary disclosure of a non-cash financing transaction:
        		                                       
          decrease to ordinary shares at par value and apic related to shares repurchased and unsettled
        		                                       
          increase to current debt obligations related to unsettled shares
        		                                       
          gain on disposal of assets
        		                                       
          income from equity method investments
        		                                   3,536,000 2,717,000   
          loans to associates
        		                                       
          other financial assets and liabilities
        		                                   781,000 -482,000   
          depreciation and amortization
        		                                    23,568,000   
          loss on disposal of assets
        		                                    150,000   
          unrealized (gain) loss in foreign currency transactions
        		                                    -697,000   
          current and non-current liabilities
        		                                    5,211,000   
          loans to equity-method companies
        		                                    -2,846,000   
          proceeds from exercise of options and sars for common stock
        		                                    2,541,000   
          cash flows from operating activities
        		                                       
          income from impairment of investment
        		                                       
          unrealized loss in foreign currency transactions and other
        		                                       
          changes in operating assets and liabilities
        		                                       
          cash flow from investing activities
        		                                       
          purchase of property, plant and equipment
        		                                       
          intangible asset purchases
        		                                       
          cash flows from financing activities
        		                                       
          supplementary disclosures of cash flow information
        		                                       
          supplementary disclosure of a non-cash operating transaction
        		                                       
          decrease to apic related to share-based compensation options cashed-out
        		                                       
          unrealized gain in foreign currency transactions
        		                                      1,000 
          supplementary disclosures of non-cash activity in financing:
        		                                       
          issuance of shares resulting in stock subscription receivable
        		                                      75,000